Global Ocular Gene Therapy Supply, Demand and Key Producers, 2024-2030

Page: 106

Published Date: 23 May 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Ocular Gene Therapy market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Ocular Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Ocular Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ocular Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Ocular Gene Therapy total market, 2019-2030, (USD Million)
Global Ocular Gene Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Ocular Gene Therapy total market, key domestic companies, and share, (USD Million)
Global Ocular Gene Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global Ocular Gene Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Ocular Gene Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Ocular Gene Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, Neurophth Therapeutics, Innostellar Biotherapeutics, Exegenesis Bio, Zhongyin Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Ocular Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Ocular Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Ocular Gene Therapy Market, Segmentation by Type
Gene Replacement Technology
Gene Editing Technology
Others

Global Ocular Gene Therapy Market, Segmentation by Application:
Hospitals
Diagnostics Centers
Research Institutes

Companies Profiled:
AbbVie
MeriaGTx
Regenxbio
GenSight Biologics
Astellas
Neurophth Therapeutics
Innostellar Biotherapeutics
Exegenesis Bio
Zhongyin Technology

Key Questions Answered
1. How big is the global Ocular Gene Therapy market?
2. What is the demand of the global Ocular Gene Therapy market?
3. What is the year over year growth of the global Ocular Gene Therapy market?
4. What is the total value of the global Ocular Gene Therapy market?
5. Who are the Major Players in the global Ocular Gene Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Ocular Gene Therapy Introduction
    1.2 World Ocular Gene Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Ocular Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Ocular Gene Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.3 China Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company Ocular Gene Therapy Revenue (2019-2030)
        1.3.8 India Based Company Ocular Gene Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Ocular Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Ocular Gene Therapy Consumption Value (2019-2030)
    2.2 World Ocular Gene Therapy Consumption Value by Region
        2.2.1 World Ocular Gene Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Ocular Gene Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Ocular Gene Therapy Consumption Value (2019-2030)
    2.4 China Ocular Gene Therapy Consumption Value (2019-2030)
    2.5 Europe Ocular Gene Therapy Consumption Value (2019-2030)
    2.6 Japan Ocular Gene Therapy Consumption Value (2019-2030)
    2.7 South Korea Ocular Gene Therapy Consumption Value (2019-2030)
    2.8 ASEAN Ocular Gene Therapy Consumption Value (2019-2030)
    2.9 India Ocular Gene Therapy Consumption Value (2019-2030)

3 World Ocular Gene Therapy Companies Competitive Analysis
    3.1 World Ocular Gene Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Ocular Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Ocular Gene Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Ocular Gene Therapy in 2023
    3.3 Ocular Gene Therapy Company Evaluation Quadrant
    3.4 Ocular Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Ocular Gene Therapy Market: Region Footprint
        3.4.2 Ocular Gene Therapy Market: Company Product Type Footprint
        3.4.3 Ocular Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Ocular Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Ocular Gene Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Ocular Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Ocular Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Ocular Gene Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Ocular Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Ocular Gene Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Ocular Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Ocular Gene Therapy Revenue, (2019-2024)
    4.4 China Based Companies Ocular Gene Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Ocular Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Ocular Gene Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Ocular Gene Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Ocular Gene Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Ocular Gene Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Ocular Gene Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Gene Replacement Technology
        5.2.2 Gene Editing Technology
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Ocular Gene Therapy Market Size by Type (2019-2024)
        5.3.2 World Ocular Gene Therapy Market Size by Type (2025-2030)
        5.3.3 World Ocular Gene Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Ocular Gene Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Diagnostics Centers
        6.2.3 Research Institutes
    6.3 Market Segment by Application
        6.3.1 World Ocular Gene Therapy Market Size by Application (2019-2024)
        6.3.2 World Ocular Gene Therapy Market Size by Application (2025-2030)
        6.3.3 World Ocular Gene Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Details
        7.1.2 AbbVie Major Business
        7.1.3 AbbVie Ocular Gene Therapy Product and Services
        7.1.4 AbbVie Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 AbbVie Recent Developments/Updates
        7.1.6 AbbVie Competitive Strengths & Weaknesses
    7.2 MeriaGTx
        7.2.1 MeriaGTx Details
        7.2.2 MeriaGTx Major Business
        7.2.3 MeriaGTx Ocular Gene Therapy Product and Services
        7.2.4 MeriaGTx Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 MeriaGTx Recent Developments/Updates
        7.2.6 MeriaGTx Competitive Strengths & Weaknesses
    7.3 Regenxbio
        7.3.1 Regenxbio Details
        7.3.2 Regenxbio Major Business
        7.3.3 Regenxbio Ocular Gene Therapy Product and Services
        7.3.4 Regenxbio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Regenxbio Recent Developments/Updates
        7.3.6 Regenxbio Competitive Strengths & Weaknesses
    7.4 GenSight Biologics
        7.4.1 GenSight Biologics Details
        7.4.2 GenSight Biologics Major Business
        7.4.3 GenSight Biologics Ocular Gene Therapy Product and Services
        7.4.4 GenSight Biologics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 GenSight Biologics Recent Developments/Updates
        7.4.6 GenSight Biologics Competitive Strengths & Weaknesses
    7.5 Astellas
        7.5.1 Astellas Details
        7.5.2 Astellas Major Business
        7.5.3 Astellas Ocular Gene Therapy Product and Services
        7.5.4 Astellas Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Astellas Recent Developments/Updates
        7.5.6 Astellas Competitive Strengths & Weaknesses
    7.6 Neurophth Therapeutics
        7.6.1 Neurophth Therapeutics Details
        7.6.2 Neurophth Therapeutics Major Business
        7.6.3 Neurophth Therapeutics Ocular Gene Therapy Product and Services
        7.6.4 Neurophth Therapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Neurophth Therapeutics Recent Developments/Updates
        7.6.6 Neurophth Therapeutics Competitive Strengths & Weaknesses
    7.7 Innostellar Biotherapeutics
        7.7.1 Innostellar Biotherapeutics Details
        7.7.2 Innostellar Biotherapeutics Major Business
        7.7.3 Innostellar Biotherapeutics Ocular Gene Therapy Product and Services
        7.7.4 Innostellar Biotherapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Innostellar Biotherapeutics Recent Developments/Updates
        7.7.6 Innostellar Biotherapeutics Competitive Strengths & Weaknesses
    7.8 Exegenesis Bio
        7.8.1 Exegenesis Bio Details
        7.8.2 Exegenesis Bio Major Business
        7.8.3 Exegenesis Bio Ocular Gene Therapy Product and Services
        7.8.4 Exegenesis Bio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Exegenesis Bio Recent Developments/Updates
        7.8.6 Exegenesis Bio Competitive Strengths & Weaknesses
    7.9 Zhongyin Technology
        7.9.1 Zhongyin Technology Details
        7.9.2 Zhongyin Technology Major Business
        7.9.3 Zhongyin Technology Ocular Gene Therapy Product and Services
        7.9.4 Zhongyin Technology Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Zhongyin Technology Recent Developments/Updates
        7.9.6 Zhongyin Technology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Ocular Gene Therapy Industry Chain
    8.2 Ocular Gene Therapy Upstream Analysis
    8.3 Ocular Gene Therapy Midstream Analysis
    8.4 Ocular Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Ocular Gene Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Ocular Gene Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Ocular Gene Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Ocular Gene Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Ocular Gene Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Ocular Gene Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Ocular Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Ocular Gene Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Ocular Gene Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Ocular Gene Therapy Players in 2023
 Table 12. World Ocular Gene Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Ocular Gene Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key Ocular Gene Therapy Players
 Table 15. Ocular Gene Therapy Market: Company Product Type Footprint
 Table 16. Ocular Gene Therapy Market: Company Product Application Footprint
 Table 17. Ocular Gene Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China Ocular Gene Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Ocular Gene Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Ocular Gene Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Ocular Gene Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Ocular Gene Therapy Revenue Market Share (2019-2024)
 Table 23. China Based Ocular Gene Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Ocular Gene Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Ocular Gene Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Ocular Gene Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Ocular Gene Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Ocular Gene Therapy Revenue Market Share (2019-2024)
 Table 29. World Ocular Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Ocular Gene Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Ocular Gene Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Ocular Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Ocular Gene Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Ocular Gene Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. AbbVie Basic Information, Manufacturing Base and Competitors
 Table 36. AbbVie Major Business
 Table 37. AbbVie Ocular Gene Therapy Product and Services
 Table 38. AbbVie Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. AbbVie Recent Developments/Updates
 Table 40. AbbVie Competitive Strengths & Weaknesses
 Table 41. MeriaGTx Basic Information, Manufacturing Base and Competitors
 Table 42. MeriaGTx Major Business
 Table 43. MeriaGTx Ocular Gene Therapy Product and Services
 Table 44. MeriaGTx Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. MeriaGTx Recent Developments/Updates
 Table 46. MeriaGTx Competitive Strengths & Weaknesses
 Table 47. Regenxbio Basic Information, Manufacturing Base and Competitors
 Table 48. Regenxbio Major Business
 Table 49. Regenxbio Ocular Gene Therapy Product and Services
 Table 50. Regenxbio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Regenxbio Recent Developments/Updates
 Table 52. Regenxbio Competitive Strengths & Weaknesses
 Table 53. GenSight Biologics Basic Information, Manufacturing Base and Competitors
 Table 54. GenSight Biologics Major Business
 Table 55. GenSight Biologics Ocular Gene Therapy Product and Services
 Table 56. GenSight Biologics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. GenSight Biologics Recent Developments/Updates
 Table 58. GenSight Biologics Competitive Strengths & Weaknesses
 Table 59. Astellas Basic Information, Manufacturing Base and Competitors
 Table 60. Astellas Major Business
 Table 61. Astellas Ocular Gene Therapy Product and Services
 Table 62. Astellas Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Astellas Recent Developments/Updates
 Table 64. Astellas Competitive Strengths & Weaknesses
 Table 65. Neurophth Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 66. Neurophth Therapeutics Major Business
 Table 67. Neurophth Therapeutics Ocular Gene Therapy Product and Services
 Table 68. Neurophth Therapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Neurophth Therapeutics Recent Developments/Updates
 Table 70. Neurophth Therapeutics Competitive Strengths & Weaknesses
 Table 71. Innostellar Biotherapeutics Basic Information, Manufacturing Base and Competitors
 Table 72. Innostellar Biotherapeutics Major Business
 Table 73. Innostellar Biotherapeutics Ocular Gene Therapy Product and Services
 Table 74. Innostellar Biotherapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Innostellar Biotherapeutics Recent Developments/Updates
 Table 76. Innostellar Biotherapeutics Competitive Strengths & Weaknesses
 Table 77. Exegenesis Bio Basic Information, Manufacturing Base and Competitors
 Table 78. Exegenesis Bio Major Business
 Table 79. Exegenesis Bio Ocular Gene Therapy Product and Services
 Table 80. Exegenesis Bio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Exegenesis Bio Recent Developments/Updates
 Table 82. Exegenesis Bio Competitive Strengths & Weaknesses
 Table 83. Zhongyin Technology Basic Information, Manufacturing Base and Competitors
 Table 84. Zhongyin Technology Major Business
 Table 85. Zhongyin Technology Ocular Gene Therapy Product and Services
 Table 86. Zhongyin Technology Ocular Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Zhongyin Technology Recent Developments/Updates
 Table 88. Zhongyin Technology Competitive Strengths & Weaknesses
 Table 89. Global Key Players of Ocular Gene Therapy Upstream (Raw Materials)
 Table 90. Global Ocular Gene Therapy Typical Customers


List of Figures
 Figure 1. Ocular Gene Therapy Picture
 Figure 2. World Ocular Gene Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Ocular Gene Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Ocular Gene Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Ocular Gene Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Ocular Gene Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. Ocular Gene Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Ocular Gene Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Ocular Gene Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Ocular Gene Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Ocular Gene Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Ocular Gene Therapy Markets in 2023
 Figure 27. United States VS China: Ocular Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Ocular Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Ocular Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Ocular Gene Therapy Market Size Market Share by Type in 2023
 Figure 31. Gene Replacement Technology
 Figure 32. Gene Editing Technology
 Figure 33. Others
 Figure 34. World Ocular Gene Therapy Market Size Market Share by Type (2019-2030)
 Figure 35. World Ocular Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Ocular Gene Therapy Market Size Market Share by Application in 2023
 Figure 37. Hospitals
 Figure 38. Diagnostics Centers
 Figure 39. Research Institutes
 Figure 40. World Ocular Gene Therapy Market Size Market Share by Application (2019-2030)
 Figure 41. Ocular Gene Therapy Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AbbVie
MeriaGTx
Regenxbio
GenSight Biologics
Astellas
Neurophth Therapeutics
Innostellar Biotherapeutics
Exegenesis Bio
Zhongyin Technology

Related Reports

Global Ocular Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Ocular Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 23 May 2024

date Medical Care

According to our (Global Info Research) latest study, the global Ocular Gene Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Ocular Gene Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>